Keywords: CLM, cutaneous leiomyoma; HLRCC, hereditary leiomyomatosis and renal cell cancer; NF-1, neurofibromatosis type 1; RCC, renal cell carcinoma; hereditary leiomyomatosis and renal cell cancer; neurofibromatosis type 1.